Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

Barclays analyst Christopher Pasquale has initiated coverage on Inspire Medical Systems (NYSE: INSP) with an Underweight rating. The firm has set a price target of $65 for the company's stock.